Ask Dr. Nandi: FDA approves 1st single-dose generic flu treatment ahead of flu season

The FDA approved the first generic version of Xofluza, a single-dose antiviral flu treatment for people aged 5 and older with symptoms for no more than 48 hours. The generic drug, containing baloxavir marboxil, offers convenience and affordability but is not a substitute for the flu vaccine.